↑ Rising
Business
🔮 fades
Moderna mRNA vaccine almost halves the risk of skin cancer returning
Moderna’s melanoma mRNA shot slashes recurrence risk by about half, sparking clinical hope and a sharp stock dip.
Oncology
83 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Oncology
This hub groups 83 separate news trends connected to Oncology, spanning June 19, 2026 through October 23, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 611 article observations and 588 source signals, led by Health, Business, Science coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Health
🔮 fades ✓
As Politicians Argue About China, US Patients Find Cutting-Edge Treatment There
U.S. cancer patients are fleeing domestic drug delays, seeking experimental Chinese therapies despite political tensions.
◼ Archived
Business
🔮 fades ✓
Cancer Vaccines Are the N.I.H.’s Next ‘Big Bet’
NIH to launch a cancer vaccine initiative
◼ Archived
Health
🔮 fades ✓
Breast cancer can show up on the skin. Here's what to know
Breast cancer can show up on the skin, but what does this mean for patients and their families?
◼ Archived
Health
🔮 fades ✓
Common Antidepressants Could Have an Unexpected Role in Cancer Survival
Unexpected link found between antidepressants and cancer survival rates.
◼ Archived
Health
🔮 fades ✓
The healthiest way to drink coffee, according to a nutritionist
A nutritionist’s top tip for coffee lovers sparks a wave of expert debate on dosage and health impact.
◼ Archived
Technology
🔮 fades ✓
AI co-scientists are revolutionizing how research is done
5 news sources are covering this Technology story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Local oncologist urges West Texans to increase cancer screenings for early detection
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
A melanoma vaccine was hailed as a breakthrough. Which cancers are next?
Breakthrough melanoma vaccine raises hopes for cancer treatment, but which cancers are next?
◼ Archived
Health
🔮 fades ✓
Oncologist shares hidden warning signs of deadly female cancer
Oncologist reveals hidden warning signs of deadly female cancer
◼ Archived
Science
🔮 fades ✓
Protein-based MRI agent detects lung cancer and hidden metastases earlier than current scans
A newly developed protein-based MRI agent detects lung cancer and hidden metastases earlier than current scans without using radiation.
◼ Archived
Health
🔮 fades ✓
AI is unlocking a new ‘golden age’ in medicine, with personalized treatments to cure cancer and potential to save billions of lives
AI is unlocking a new ‘golden age’ in medicine, with personalized treatments to cure cancer and potential to save billions of lives
◼ Archived
Health
🔮 fades ✓
Scientists make concerning discovery about lung cancer and microplastics
New Greek study finds lung cancer patients harbor more microplastics, sparking health and environmental concerns
◼ Archived
Business
CBER official overruled review team’s rejection of new Replimune melanoma drug
An official within the FDA's CBER overruled a review team's initial rejection of a new Replimune melanoma drug.
◼ Archived
Health
🔮 fades ✓
Urine test can spot more than nine in 10 bladder cancers
A non-invasive urine test has been shown in trials to identify a vast majority of bladder cancer cases.
◼ Archived
Business
🔮 fades ✓
Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion
Thyme Care secures $125 million in a Series E financing round, pushing the oncology startup's valuation past $2 billion.
◼ Archived
Health
🔮 fades ✓
Early-onset bowel cancer shows distinct biological and clinical features - News-Medical
Early-onset bowel cancer exhibits distinct biological and clinical features compared to cases diagnosed in older adults.
◼ Archived
Health
🔮 fades ✓
Column | I’m an oncologist. Every man should know this about prostate cancer.
A 3 % yearly rise in prostate cancer and more late‑stage diagnoses are driving urgent calls for men over 50 to get screened.
◼ Archived
Health
🔮 fades ✓
Dolly Parton’s private cancer battle highlights why some patients don’t share their diagnoses
Dolly Parton's death has sparked conversations about cancer disclosure and prevention.
◼ Archived
Business
Genentech doubles down on ADC-resistance via $1B DualityBio pact
Genentech's $1B bet on DualityBio's ADC technology signals a major shift in cancer treatment strategies.
◼ Archived
Health
🔮 fades ✓
NUS researchers find drug that turns off ‘master switch’ in aggressive breast cancer
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
'Game changer': Cancer center opens at Park City Hospital
A new cancer center at Park City Hospital is set to transform cancer treatment in the Wasatch Back region
◼ Archived
Health
🔮 fades ✓
Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?
New data on prostate cancer treatment has divided physicians, with active surveillance rates rising and focal therapy use under scrutiny.
◼ Archived
Health
🔮 fades ✓
New Treatments Show Promise for Two of the Most Deadly Types of Cancer
Eight studies published on August 21, 2026, suggest new hope for patients with brain tumors and another deadly cancer
◼ Archived
Health
🔮 fades ✓
Experimental Drug Generates Immune Response Against Pancreatic Cancer in People at High Risk
An experimental vaccine is generating immune responses against pancreatic cancer in high-risk individuals, according to early clinical findings.
◼ Archived
Health
🔮 fades ✓
Key Diet Factor Linked to Prevalence of One of Deadliest Cancers
A study has found that a diet rich in antioxidants may significantly lower the odds of developing cervical cancer.
◼ Archived
Health
New study finds link between sugary drinks and stomach cancer
A new medical study establishes a correlation between daily consumption of sugary drinks and an increased risk of stomach cancer.
◼ Archived
Health
Scientists Discover a New Organ Hiding in The Skull
Medical researchers have identified previously unknown immune structures within the human skull, potentially reshaping brain cancer treatment.
◼ Archived
Business
🔮 fades ✓
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
Moderna's stock surged 160% after the company and Merck announced success in a late-stage melanoma vaccine trial
◼ Archived
Health
Prostate cancer can be diagnosed without invasive biopsy, study finds
A new study indicates that MRI scans may eliminate the necessity for invasive biopsies in diagnosing prostate cancer for many patients.
◼ Archived
Business
New St. Jude CEO Dr. Charles Roberts says childhood cancer treatments are at 'the dawn of a new era'
St. Jude Children's Research Hospital has a new leader who envisions a new era in childhood cancer treatments
◼ Archived
Health
🔮 fades ✓
Flight attendants and pilots have highest risk of dying from radiation-linked cancers, study says
A new study has found that flight attendants and pilots face the highest risk of dying from radiation-linked cancers.
◼ Archived
Health
🔮 fades ✓
Just One Intense Sunburn Can Change Your Health Forever, Research Shows
New research suggests that even a single instance of severe sunburn may permanently alter long-term skin health and increase cancer risk.
◼ Archived
Health
Lung cancer can stay silent for years: Who should get screened and why early detection matters
Medical experts and health outlets are spotlighting the vital role of early screening to combat the long-term silent progression of lung cancer.
◼ Archived
Business
🔮 fades ✓
AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review
AstraZeneca has abruptly terminated its Phase 3 trial for the lung cancer drug volrustomig, halting development after an internal review.
◼ Archived
Business
🔮 fades ✓
FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class
Bristol Myers Squibb's new multiple myeloma drug Zenbexus™ debuts as a novel treatment class, but the company faces financial pressure from generic competition.
◼ Archived
Health
🔮 fades ✓
I’m a Gastroenterologist. These 3 Colon Cancer Symptoms Fool Most People
A gastroenterologist warns of colon cancer symptoms often dismissed as signs of aging.
◼ Archived
Business
Cullinan tees up J&J fight—and $100M payday—as Taiho-partnered drug hits phase 3 cancer goal
Cullinan and Taiho's lung cancer drug has passed a major clinical trial, setting up a potential challenge to Johnson & Johnson's market-leading treatment.
◼ Archived
Health
🔮 fades ✓
More Young People Than Ever Before Are Getting One Type of Cancer, And It's Mystifying Scientists
Colorectal cancer rates are rising among young adults, baffling scientists and raising alarms.
◼ Archived
World
🔮 fades ✓
Gaza cancer patients face rising death rate amid Israeli curbs, doctors say
Cancer patients in Gaza face a rising death rate due to Israeli restrictions on medical access.
◼ Archived
Health
Non-Smoker, 38, Diagnosed With Stage 4 Lung Cancer After Doctors Dismissed Symptoms: ‘Nobody Was Worried’
Two non-smokers, an 11-year-old girl and a 38-year-old woman, have been diagnosed with stage 4 lung cancer.
◼ Archived
Business
🔮 fades ✓
AI brings savings to clinical trials: study
Research indicates AI integration could deliver 82 times the return on investment in oncology clinical trials while reshaping the drug development market.
◼ Archived
Health
🔮 fades ✓
Lung cancer is not only about smoking: Doctor explains the risks hiding in your air, home and daily routine
Medical discourse is shifting focus toward non-smoking related lung cancer, highlighting environmental and domestic hazards alongside technological screening tools.
◼ Archived
Health
🔮 fades ✓
Oral nano-delivery of a gut microbial metabolite enhances T cell stemness for cancer immunotherapy
Researchers have developed an oral nanomedicine that utilizes gut microbial metabolites to boost T cell effectiveness in cancer immunotherapy.
◼ Archived
Health
🔮 fades ✓
Could one blood test detect multiple cancers earlier? UNC researchers hope to find out
A single blood test could revolutionize cancer detection by identifying multiple cancers earlier.
◼ Archived
Health
Prostate cancer prognosis linked to prostate-specific antigen levels below threshold
New research suggests that prostate-specific antigen levels below a certain threshold may predict prostate cancer prognosis.
◼ Archived
Health
🔮 fades ✓
Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’
Patients in Illinois and Utah are among the first to receive a new experimental drug for pancreatic cancer.
◼ Archived
Health
The Early Prostate Cancer Symptoms Too Many Men Don’t Realize Could Be Warning Signs
Health experts and medical organizations are highlighting the necessity of recognizing early prostate cancer symptoms to encourage timely medical screening.
◼ Archived
Science
Scientists have found a cell that fights infection by detonating. It bursts, kills everything within reach, and five minutes later there is nothing left to show it was ever there
Scientists have discovered a unique immune cell that sacrifices itself to fight infections.
◼ Archived
Health
🔮 fades ✓
High glucose thickens cancer cells' sugar shield, helping them evade immune attack
Research identifies high glucose levels as a factor in the thickening of cancer cells' sugar shields, potentially masking them from the immune system.
◼ Archived
Health
🔮 fades ✓
DCAF11-dependent molecular glue degrader activated by glutathionylation
Researchers at Dana-Farber have engineered a molecular glue platform that utilizes DCAF11-dependent degradation activated by glutathionylation.
◼ Archived
Science
ZFP36L2 orchestrates stress-adaptive plasticity in regeneration and cancer
Research identifies the ZFP36L2 protein as a critical molecular switch in both gut tissue regeneration and colorectal cancer progression.
◼ Archived
Health
🔮 fades ✓
Experimental Cancer Drug Force-Feeds Tumors Sugar Until They Choke
A newly developed covalent PFKL activator forces cancer cells to consume excess sugar, effectively stuntng tumor growth through metabolic overload.
◼ Archived
Health
🔮 fades ✓
A compendium of next-generation patient-derived models for diverse cancers
Researchers have created a vast library of next-generation cancer models, accelerating drug development and personalized medicine.
◼ Archived
Health
🔮 fades ✓
Ask An Expert: What You Need to Know About Lung Cancer Testing
Lung cancer testing is evolving rapidly, with new advancements and barriers shaping patient care.
◼ Archived
Health
🔮 holds ✗
Pancreatic cancer drug now available in Cleveland offers new hope
Medical advancements in pancreatic cancer treatment, specifically involving Daraxonrasib and RASolute-302 data, are expanding patient access in clinical settings.
◼ Archived
Health
🔮 fades ✓
A common sugar may help cancer cells break free and spread
A new study links a common dietary sugar to the spread of ovarian cancer.
◼ Archived
Health
🔮 fades ✓
Cancer-fighting antibodies with a one-two punch take aim at tumours
Engineered bispecific antibodies are targeting B-cell lymphoma by simultaneously engaging tumor cells and activating macrophages to destroy them.
◼ Archived
Health
🔮 fades ✓
Why more young adults are being diagnosed with colon cancer: Oncologist Dr Ravi K Gupta shares risk factors and symptoms
Medical reports are converging on a surge in early-onset colorectal cancer diagnoses among younger populations.
◼ Archived
Health
🔮 fades ✓
In world first, Israeli scientists find active ingredient in Viagra may stop cancer spread
Scientists in Israel have identified that the active ingredient in Viagra may possess the capability to hinder the spread of cancer.